These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21789883)

  • 21. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism.
    Li J; Zhang P; Zhang QY; Zhang SM; Guo HT; Bi H; Wang YM; Sun X; Liu JC; Cheng L; Cui Q; Yu SQ; Kaye AD; Yi DH; Pei JM
    Vascul Pharmacol; 2009; 51(2-3):72-7. PubMed ID: 19351568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch activation of Ca
    Guo Q; Xu H; Yang X; Zhao D; Liu S; Sun X; Huang JA
    Hypertens Res; 2017 Feb; 40(2):117-129. PubMed ID: 27581537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
    Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
    Lung; 2007; 185(5):303-308. PubMed ID: 17721804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion exchange activity in pulmonary artery smooth muscle cells: the response to hypoxia.
    Madden JA; Ray DE; Keller PA; Kleinman JG
    Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L264-71. PubMed ID: 11159005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
    Tan JX; Huang XL; Wang B; Fang X; Huang DN
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice.
    Yu L; Quinn DA; Garg HG; Hales CA
    Circ Res; 2005 Oct; 97(9):937-45. PubMed ID: 16195480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia.
    Favret F; Henderson KK; Allen J; Richalet JP; Gonzalez NC
    J Appl Physiol (1985); 2006 Jan; 100(1):20-5. PubMed ID: 16179398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.
    Huang X; Fan R; Lu Y; Yu C; Xu X; Zhang X; Liu P; Yan S; Chen C; Wang L
    Mol Biol Rep; 2014 Jun; 41(6):4031-41. PubMed ID: 24566685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells.
    Jin H; Wang Y; Zhou L; Liu L; Zhang P; Deng W; Yuan Y
    J Pineal Res; 2014 Nov; 57(4):442-50. PubMed ID: 25251287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of endogenous sulfur dioxide in the regulation of cardiovascular system].
    Jin HF; DU SX; Zhao X; Zhang SQ; Tian Y; Bu DF; Tang CS; DU JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 39(4):423-5. PubMed ID: 17657274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced alpha1-adrenergic trophic activity in pulmonary artery of hypoxic pulmonary hypertensive rats.
    Faber JE; Szymeczek CL; Salvi SS; Zhang H
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2272-81. PubMed ID: 16798826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
    Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
    Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension.
    Zhou Y; Tian X; Wang X; Wang Y; Fan R; Wang Y; Feng N; Zhang S; Guo H; Gu X; Jia M; Yin W; Hou Z; Li J; Pei J
    Eur J Pharmacol; 2018 Aug; 832():129-137. PubMed ID: 29782857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docosahexaenoic acid inhibits development of hypoxic pulmonary hypertension: in vitro and in vivo studies.
    Yan J; Chen R; Liu P; Gu Y
    Int J Cardiol; 2013 Oct; 168(4):4111-6. PubMed ID: 23907044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
    Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
    J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of potassium channel by chronic hypoxia on pulmonary artery smooth muscle cells in rats].
    Xiao X; Chen W; Cheng D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):681-5. PubMed ID: 11477898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor.
    Zhao L; Hughes JM; Winter RJ
    Cardiovasc Res; 1994 Apr; 28(4):519-23. PubMed ID: 8181040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.